Description
Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries: Present Challenges and Future Solutions examines the particularities of low- and middle-income countries and offers solutions based on their needs, culture and available resources. Drawing from the firsthand experience of researchers and practitioners working in these countries, this book addresses the socio-behavioral aspects of pharmacy and health, pharmacoeconomics, pharmaceutical policy, supply management and marketing, pharmacoepidemiology and public health pharmacy specific to low- and middle-income countries.While some practices may be applied appropriately in disparate places, too often pharmacy practice in low- and middle-income countries is directly copied from successes in developed countries, despite the unique needs and challenges low- and middle-income countries face.- Examines key issues and challenges of pharmacy practice and the pharmaceutical sector specific to low- and middle-income countries- Compares pharmacy practice in developed and developing countries to highlight the unique challenges and opportunities of each- Provides a blueprint for the future of pharmacy in low- and middle-income countries, including patient-centered care, evidence-based care and promoting the role of the pharmacist for primary health care in these settings
Table of Contents
1. Introduction: Discovering Issues and Challenges in Low- and Middle-Income CountriesSection I: Socio-behavioral Aspects of Medicines Used in Low- and Middle-Income Countries2. Socio-Behavioral Aspects of Medicine Used in Low- and Middle-Income Countries3. Patients', Consumers' and Healthcare Professionals' Perceptions, Beliefs, Knowledge, Attitudes and Practices Towards the Use of Medicines4. The Use of Measurements and Health Behavioral Models to Improve Medication AdherenceSection II: Pharmaceutical Promotion in Low- and Middle-Income Countries5. Academic Detailing in Low- and Middle-Income Countries: Principles, Use, Impact and Lessons LearnedSection III: Economic Evaluation and Medicine Expenditure in Low- and Middle-Income Countries6. Economic Evaluation and Medicine Expenditure in Low- and Middle-Income Countries7. Medicine Pricing Policy and Strategies in Low- and Middle-Income Countries: A Review 8. Economic Evaluation of Predominant Disease in Low- and Middle-Income Countries: Diabetes MellitusSection IV: Pharmacovigilance and Patient Safety in Low- and Middle-Income Countries9. Pharmacovigilance Practices and Activities: Issues, Challenges, and Future Direction10. Behavioral Aspects of Pharmacovigilance: Research Methods Considerations11. Knowledge, Attitude, and Practice of Pharmacovigilance in Low- and Middle-Income CountriesSection V: Generic Medicines Used in Low- and Middle-Income Countries12. Overcoming Challenges of Generic Medicine Utilization in Low- and Middle-Income Countries: Lessons Learned from International Experiences13. Assessment of Policies, Determinants and Characteristics of Generic Medicine Entry into the Pharmaceutical MarketsSection VI: Rational and Responsible Medicine Use in Low- and Middle-Income Countries14. Misconceptions and Misues of Drugs by Prescribers, Dispensers and Consumers15. Strengths and Weaknesses of Pharmaceutical Policy in Relation to Rational and Responsible Medicines Use16. Rational and Responsible Medicines UseSection VII: Quality of Public Health Pharmacy Services in Low- and Middle-Income Countries17. Quality of Pharmacy Health Services18. Assessment of Medicine Dispensing and Extended Community Pharmacy Services19. Enhancing Quality of Patient-Centered Care Services in Low- and Middle-Income Countries: Pharmaceutical Care Approach20. Politics and Competition between Professions: Future Scope of Pharmacy PracticeSection VIII: Medicine Quality: Substandard and Counterfeit Medicine in Low- and Middle-Income Countries21. Perspective, Knowledge, Attitude, and Belief of Various Stakeholders on Medicines Quality: Counterfeit and Substandard MedicinesSection IX: Medicine Information and Health Literacy in Low- and Middle-Income Countries22. Issues on Source, Access, Extent and Quality of Information Available Among Pharmacists and Pharmacy Personnel to Practice EffectivelySection X: Good Governance and Pharmaceutical Policy in Low- and Middle-Income Countries23. Problems and Obstacles of Low- and Middle-Income Countries in Having Good Governance and Quality and Effective Pharmaceutical Policy24. Pharmacogovernance: Advancing Pharmacovigilance and Patient Safety25. Pharmaceutical Policy: Synthesis, Themes and Future Directions
